ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Grifols Sa (PK)

Grifols Sa (PK) (GIFLF)

10.68
0.00
( 0.00% )
Updated: 14:17:37

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
10.68
Bid
9.96
Ask
10.80
Volume
-
0.00 Day's Range 0.00
7.4599 52 Week Range 15.80
Market Cap
Previous Close
10.68
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
5,090
Shares Outstanding
687,554,908
Dividend Yield
-
PE Ratio
123.75
Earnings Per Share (EPS)
0.09
Revenue
6.59B
Net Profit
59.32M

About Grifols Sa (PK)

Sector
Medicinal Chems,botanicl Pds
Industry
In Vitro,in Vivo Diagnostics
Website
Headquarters
Barcelona, Catalonia, Esp
Founded
1987
Grifols Sa (PK) is listed in the Medicinal Chems,botanicl Pds sector of the OTCMarkets with ticker GIFLF. The last closing price for Grifols (PK) was $10.68. Over the last year, Grifols (PK) shares have traded in a share price range of $ 7.4599 to $ 15.80.

Grifols (PK) currently has 687,554,908 shares outstanding. The market capitalization of Grifols (PK) is $7.34 billion. Grifols (PK) has a price to earnings ratio (PE ratio) of 123.75.

GIFLF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10010.6810.6810.68128610.68CS
40.08990.84890605376710.590111.159.43165110.24310936CS
121.8821.36363636368.811.158.4650909.48912734CS
26-5.12-32.405063291115.815.87.459983659.03673712CS
52-1.92-15.238095238112.615.87.459973559.93381313CS
156-15.7645-59.613530223726.444528.4897.4599603417.10859853CS
260-15.2069-58.743611633725.886936.18177.4599559821.49289641CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALBTAvalon GloboCare Corporation
$ 1.2795
(333.73%)
107.76M
TOIIWOncology Institute Inc
$ 0.0315
(96.88%)
36.01k
GPCRStructure Therapeutics Inc
$ 58.31
(70.50%)
9.67M
AFMDAffimed NV
$ 7.10
(63.22%)
26.12M
MBOTMicrobot Medical Inc
$ 1.47
(47.00%)
145.7M
CAMPCalAmp Corp
$ 1.085
(-59.36%)
2.05M
INBXInhibrx Biosciences Inc
$ 16.91
(-50.43%)
248.54k
VWEVintage Wine Estates Inc
$ 0.225
(-36.97%)
2.22M
PRTGPortage Biotech Inc
$ 0.3171
(-33.79%)
1.13M
CNSPCNS Pharmaceuticals Inc
$ 0.1433
(-33.72%)
6.36M
CRKNCrown Electrokinetics Corporation
$ 0.1109
(10.90%)
262.13M
FFIEFaraday Future Intelligent Electric Inc
$ 0.6477
(11.02%)
206.89M
MBOTMicrobot Medical Inc
$ 1.47
(47.00%)
145.7M
SQQQProShares UltraPro Short QQQ
$ 10.13
(1.10%)
108.91M
ALBTAvalon GloboCare Corporation
$ 1.2795
(333.73%)
107.76M

Discussion

View Full Feed
stockinspector stockinspector 3 minutes ago
Quarterly Report
https://www.otcmarkets.com/otcapi/company/financial-report/405306/content
Annual Report
https://www.otcmarkets.com/otcapi/company/financial-report/405305/content
WDLF
ShadowDiviner72 ShadowDiviner72 3 minutes ago
Yeah 3 weeks ago.. mid may.. study completion date June 2024... So yeah, after 5 years... 3 weeks seems 'imminent'. So, I hope it will be this week
JAGX
PennyMillions852 PennyMillions852 3 minutes ago
Damn that ask is huge!!!
CBIA
FlyingDutchman FlyingDutchman 3 minutes ago
NKGN wont be ready till sept.
NKGN
Monksdream Monksdream 3 minutes ago
IMMR new 52 week high
https://investorshub.advfn.com/uimage/uploads/2024/6/3/tsjsmIMG_8573.gif
IMMR
Hicham007 Hicham007 4 minutes ago
Thanks BG. I can see the quality of debate here is very different.
IOVA
 just Scottie just Scottie 4 minutes ago
I don’t think Chad is concerned at the moment, will there be time where is is? That’s up for debate. If he wanted movement in the stock price or show that he cares he would at least remove access to mavins jewelry eBay account on x
SFLM
Lone Clone Lone Clone 4 minutes ago
Silver Storm Adds Second Drill Rig and Commences Phase 2 Drill Program at La Parrilla

https://ca.finance.yahoo.com/news/silver-storm-adds-second-drill-113000606.html

Business Wire
Mon, June 3, 2024 at 4:30 a.m. PDT·12 min read

SVRSF
-3.20%
SVRSF
splintered sunlight splintered sunlight 4 minutes ago
I'm a buyer under a penny.....
FLCX
diggitydoodle diggitydoodle 4 minutes ago
"Don't expect anything until filings hit. "
Well, there's some great advice.
Believe me, folks are a lot more tired of endless pumping, than me just telling it like it is. We'll, not the pumpers.
RNVA!!$$$$$??????
RNVA
wadegarret wadegarret 5 minutes ago
One stock can't keep this market going up

NVDA is the ONLY reason we haven't seen a correction yet.
NVDA
igotthemojo igotthemojo 5 minutes ago
as you said.....this is business....you are making it personal...
KBLB
dennisdave dennisdave 5 minutes ago
Let's hold the horses on the Novocure study until we did into the weeds on it. For example, what was the inclusion breakdown between methylated and unmethylated? Did they have 56% unmethylated patients as we did in our trial? It was not mentioned in the abstract. Things like this are part of the sle
NWBO
Monksdream Monksdream 5 minutes ago
JWN new 52 week high
https://investorshub.advfn.com/uimage/uploads/2024/6/3/utalqIMG_8571.gif
JWN
EnchantedMagician30 EnchantedMagician30 6 minutes ago
RCRT owns 95.5% of the shell and all the assets going into it. Whatever AESO shareholders get is a gift because they bring absolutely nothing to the deal.
The board/Miles has fiduciary responsibility to RCRT shareholders and it will be reflected in their decisions. WATCH!
AESO RCRT
jedijazz jedijazz 6 minutes ago
$CATV .00175 +2.94% Road to .01! Favorable Federal Reclassification of Specialty Botanical Unlocks Major Opportunity for Genetics Tech Acquisition-Oriented Pharmaceutical Developer: Category V Biotech, Inc. (Stock Symbol: CATV) https://www.benzinga.com/pressreleases/24/05/ab38968053/favorable-federa
CATV
jedijazz jedijazz 6 minutes ago
$CATV .00175 +2.94% Road to .01! Favorable Federal Reclassification of Specialty Botanical Unlocks Major Opportunity for Genetics Tech Acquisition-Oriented Pharmaceutical Developer: Category V Biotech, Inc. (Stock Symbol: CATV) $LTNC $GRLF $IGEX https://www.benzinga.com/pressreleases/24/05/ab3896805
CATV GRLF IGEX
Capt_Smith77 Capt_Smith77 6 minutes ago
That's all this has ever been.

You just haven't gotten the memo yet.
ENZC
brooktrail1933 brooktrail1933 7 minutes ago
Let's hold the horses on the Novocure study until we did into the weeds on it. For example, what was the inclusion breakdown between methylated and unmethylated? Did they have 56% unmethylated patients as we did in our trial? It was not mentioned in the abstract. Things like this are part of the
NWBO
art2426 art2426 7 minutes ago
>>>Name one person/poster that’s benefited from your extreme daily grind.
BIEL
Myth Myth 7 minutes ago
good stuff surfer, in case anyone wants to know the artist is Clifton Chenier.....
ThunderThirteen ThunderThirteen 8 minutes ago
CATV. I predict the LOI closes next week. Then the true story and plans get releases and I sense they are really big!
CATV
Lime Time Lime Time 8 minutes ago
RS on 1.18B Float. What idiots.
AIAD
TRADER99 TRADER99 8 minutes ago
Lol this week I bet. Could be the easiest $ play in the otc. Stack em up big early.........
CIVX

Your Recent History

Delayed Upgrade Clock